Deciphering the role of forkhead transcription factors in cancer therapy
Forkhead O transcription factors (FOXO) are critical for the regulation of cell cycle arrest, cell
death, and DNA damage repair. Inactivation of FOXO proteins may be associated with …
death, and DNA damage repair. Inactivation of FOXO proteins may be associated with …
FOXM1 confers acquired cisplatin resistance in breast cancer cells
JMM Kwok, B Peck, LJ Monteiro, HDC Schwenen… - Molecular cancer …, 2010 - AACR
The transcription factor Forkhead box M1 (FOXM1) is a key regulator of cell proliferation and
is overexpressed in many forms of primary cancers, leading to uncontrolled cell division and …
is overexpressed in many forms of primary cancers, leading to uncontrolled cell division and …
FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
Y Wang, L Wen, S Zhao, Z Ai, J Guo, W Liu - Lung cancer, 2013 - Elsevier
BACKGROUND: The transcription factor Forkhead box M1 (FoxM1) is known to play an
important role in the development and progression of many malignancies including lung …
important role in the development and progression of many malignancies including lung …
[HTML][HTML] The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway
J Park, YS Ko, J Yoon, MA Kim, JW Park, WH Kim… - Gastric cancer, 2014 - Springer
Background Cisplatin (CDDP) is one of the most important chemotherapeutic agents in the
treatment of advanced gastric cancer, but its efficacy is limited by CDDP resistance. Because …
treatment of advanced gastric cancer, but its efficacy is limited by CDDP resistance. Because …
[HTML][HTML] Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance
F Zhao, MKY Siu, LL Jiang, KF Tam, HYS Ngan, XF Le… - PloS one, 2014 - journals.plos.org
Aim Deregulation of FOXM1 has been documented in various cancers. The aim of this study
was to evaluate the role of FOXM1 in ovarian cancer tumorigenesis and paclitaxel …
was to evaluate the role of FOXM1 in ovarian cancer tumorigenesis and paclitaxel …
FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles
Z Yang, S Jiang, Y Cheng, T Li, W Hu… - … in medical oncology, 2017 - journals.sagepub.com
Forkhead box C1 (FOXC1) is an essential member of the forkhead box transcription factors
and has been highlighted as an important transcriptional regulator of crucial proteins …
and has been highlighted as an important transcriptional regulator of crucial proteins …
FOXO transcription factors in cancer development and therapy
A Coomans de Brachène, JB Demoulin - Cellular and molecular life …, 2016 - Springer
The forkhead box O (FOXO) transcription factors are considered as tumor suppressors that
limit cell proliferation and induce apoptosis. FOXO gene alterations have been described in …
limit cell proliferation and induce apoptosis. FOXO gene alterations have been described in …
[HTML][HTML] FOXM1 and cancer: faulty cellular signaling derails homeostasis
Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as
proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue …
proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue …
[HTML][HTML] Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma
S Chen, M Yang, C Wang, Y Ouyang, X Chen, J Bai… - Cancer letters, 2021 - Elsevier
Chemotherapy regimens containing cisplatin remain the first-line treatments for patients with
oral squamous cell cancer (OSCC); however, the treatment effect is often transient because …
oral squamous cell cancer (OSCC); however, the treatment effect is often transient because …
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells
S Fernandez de Mattos, P Villalonga, J Clardy… - Molecular cancer …, 2008 - AACR
Cisplatin is a conventional chemotherapeutic agent that binds covalently to purine DNA
bases and mediates cellular apoptosis. A better understanding of the downstream cellular …
bases and mediates cellular apoptosis. A better understanding of the downstream cellular …